Innovation centre works with pharma giants on continuous manufacturing

CPI and Strathclyde University’s strategic partnership with GSK and AstraZeneca has begun work on a continuous direct compression platform for oral solid dosage medicines

picture of

Breaking News

Insilico and Janssen take another step towards predictive biomanufacturing

The digital twins collaboration will run for three years and will be based at Insilico's site in Stuttgart, Germany and ...

Cannabis testing lab adopts DNA-based microbial detection technique

CDX Analytics has installed a beta unit of LexaGene LX2 pathogen analyser at Massachusetts facility

ClpX-ClpP protein complex: The starting point for new antibiotics

Researchers in Germany have elucidated the structure of the proteolytic complex to target the degradation process of ...

The power of collaboration: Tackling pharmaceutical challenges

Pharmaceutical companies have started to embrace a more collaborative way of working as part of a movement to help ...

Astellas invests $13m in cell and gene therapy innovation incubators

Japanese Astellas’ nearly $13m will make it a Founding Sponsor of LabCentral's new incubator with a core lab space ...

Research finds more efficient drug delivery within the brain using LAT1

A new study from the University of Eastern Finland has found by converting drug molecules temporarily into LAT1 ...

Peak identification by LC/MS: Automation versus analyst

High pressure liquid chromatography/mass spectrometry (LC/MS) is an important technique that facilitates the correct ...

Review analyses the trajectory of biologic APIs

Kline review has predicted that growth of biologics and biosimilars will drive above-average demand for a range of ...

N4 Pharma enters final pre-clinical stage for novel silica delivery system

Nuvec can promote transfection using both DNA and RNA and UK-based N4 Pharma will now focus on optimising the loading ...

CPhI Pharmaceutical Machinery Report: Investment is key

The changing drugs pipeline and the industry's drive towards more efficient manufacturing define the use of modern ...

Future market dynamics and opportunities in immuno-oncology

Long-term survival, tumour-agnostic effects and the potential for cure in a fraction of patients are key catalysts ...

What happens if a company doesn’t have any records of its R&D activities?

Companies in the UK engaged in R&D can get up to 33% of innovation expenditures back. Myriad Associates explains how to ...

Science freelancing platform Kolabtree surpasses 10,000 members

More than 2,500 businesses have completed projects with the help of Kolabtree's global network of freelance experts

AstraZeneca considers nanonisation to increase bioavailability of products

Nanoform has been chosen to evaluate its proprietary CESS technology across a range of AstraZeneca’s proprietary ...